Taylor Ben R
- SEC CIK
- 0001712276
In the past year, 3 open-market sale filings worth $157.7K and no purchases.
Current role at each company
- RXRX Recursion Pharmaceuticals, Inc.Chief Financial Officeras of Sep 16, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $157.7K
- 3 filings
- Net
- −$157.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Taylor Ben R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 (view filing) | Mar 17 | 1 day | Taylor Ben RChief Financial Officer | SSaleClass A Common Stock | −7.96K | $3.39 | −$27.0K | −0.7%1.18M after | 10b5-1 |
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Taylor Ben RChief Financial Officer | SSaleClass A Common Stock | −13.4K | $3.08 | −$41.4K | −1.1%1.20M after | 10b5-1 |
| Dec 30, 2025 (view filing) | Dec 29 | 1 day | Taylor Ben RChief Financial Officer | SSaleClass A Common Stock | −21.4K | $4.18 | −$89.4K | −2.7%761.5K after | 10b5-1 |